Artigo Acesso aberto Revisado por pares

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

2019; Lippincott Williams & Wilkins; Volume: 37; Issue: 21 Linguagem: Inglês

10.1200/jco.18.01575

ISSN

1527-7755

Autores

Marcus E. Randall, Virginia L. Filiaci, D. Scott McMeekin, Vivian von Gruenigen, Helen Q. Huang, Catheryn M. Yashar, Robert S. Mannel, Jae‐Weon Kim, Ritu Salani, Paul DiSilvestro, James J. Burke, Thomas Rutherford, Nick M. Spirtos, Keith Y. Terada, Penny R. Anderson, Wendy R. Brewster, William Small, Carol Aghajanian, David S. Miller,

Tópico(s)

Endometriosis Research and Treatment

Resumo

The primary objective was to determine if vaginal cuff brachytherapy and chemotherapy (VCB/C) increases recurrence-free survival (RFS) compared with pelvic radiation therapy (RT) in high-intermediate and high-risk early-stage endometrial carcinoma.

Referência(s)